|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 15/113 | (2010.01) |
| A61K 31/7125 | (2006.01) |
| (11) | Number of the document | 3366775 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17209680.2 |
| Date of filing the European patent application | 2012-11-16 | |
| (97) | Date of publication of the European application | 2018-08-29 |
| (45) | Date of publication and mention of the grant of the patent | 2022-04-27 |
| (46) | Date of publication of the claims translation | 2022-08-10 |
| (30) | Number | Date | Country code |
| 201161561710 P | 2011-11-18 | US |
| (72) |
RAJEEV, Kallanthottathil, G. , US
ZIMMERMANN, Tracy , US
MANOHARAN, Muthiah , US
MAIER, Martin , US
KUCHIMANCHI, Satyanarayana , US
CHARISSE, Klaus , US
|
| (73) |
Alnylam Pharmaceuticals, Inc. ,
300 Third Street, Cambridge, MA 02142,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Modifikuoti RNRi agentai |
| MODIFIED RNAI AGENTS |
| Payment date | Validity (years) | Amount | |
| 2025-10-27 | 14 | 289.00 EUR |
| 2026-11-16 |